Zentek Ltd.
$0.5
▼
-3.77%
2026-04-21 10:27:00
www.zentek.com
NCM: ZTEK
Explore Zentek Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$73.33 M
Current Price
$0.5
52W High / Low
$2.5 / $0.63
Stock P/E
—
Book Value
$0.08
Dividend Yield
—
ROCE
-64.39%
ROE
-56.64%
Face Value
—
EPS
$-0.06
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
18
Beta
0.35
Debt / Equity
15.4
Current Ratio
1
Quick Ratio
1
Forward P/E
—
Price / Sales
62.37
Enterprise Value
$58.9 M
EV / EBITDA
-7.03
EV / Revenue
62.47
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Solventum Corporation | $69.51 | 7.83 | $12.08 B | — | 5.66% | 38.86% | $88.2 / $62.38 | $29.1 |
| 2. | NEXGEL, Inc. | $0.64 | — | $6.98 M | — | -41.75% | -52.74% | $2.99 / $0.56 | $0.64 |
| 3. | The Cooper Companies, Inc. | $67.65 | 33.54 | $13.23 B | 0.02% | 6.05% | 4.87% | $89.83 / $61.78 | $42.87 |
| 4. | Warby Parker Inc. | $25.89 | 1,889.51 | $3.1 B | — | -0.93% | 0.46% | $31 / $13.63 | $3 |
| 5. | Harvard Bioscience, Inc. | $6.99 | — | $30.92 M | — | 0.17% | -1.47% | $9.46 / $2.81 | $3.07 |
| 6. | Bausch + Lomb Corporation | $16.76 | — | $5.94 B | — | 1.55% | -5.39% | $18.91 / $10.45 | $18.2 |
| 7. | AngioDynamics, Inc. | $10.79 | — | $449.55 M | — | -11.8% | -17.47% | $13.99 / $8.36 | $4.16 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.07 M | 0.01 M | 0.06 M | 0.81 M | 0.04 M | — |
| Operating Profit | -2.39 M | -2.32 M | -1.8 M | -2.1 M | -2.6 M | — |
| Net Profit | -2.49 M | -2.39 M | -1.36 M | -1.84 M | -2.6 M | — |
| EPS in Rs | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 | -0.03 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.87 M | 0.03 M | 0.07 M | 0.34 M |
| Operating Profit | -9.6 M | -11.98 M | -14.65 M | -11.98 M |
| Net Profit | -10.04 M | -11.7 M | -14.41 M | -31.69 M |
| EPS in Rs | -0.09 | -0.11 | -0.13 | -0.29 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 18.4 M | 22.59 M | 33.29 M | 44.98 M |
| Total Liabilities | 3.65 M | 2.41 M | 2.9 M | 3.44 M |
| Equity | 14.75 M | 20.17 M | 30.38 M | 41.55 M |
| Current Assets | 4.37 M | 6.25 M | 17.95 M | 31.96 M |
| Current Liabilities | 3.49 M | 1.82 M | 2.42 M | 2.3 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -6.28 M | -8.05 M | -12.96 M | -7.99 M |
| Investing CF | 0.36 M | 1.88 M | -2.31 M | -7.25 M |
| Financing CF | 2.52 M | -0.67 M | -1.05 M | 38.82 M |
| Free CF | -6.47 M | -8.64 M | -15.23 M | -12.29 M |
| Capex | -0.18 M | -0.59 M | -2.27 M | -4.3 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 2826.26% | -59.07% | -78.55% | — |
| Earnings Growth % | 14.22% | 18.8% | 54.52% | — |
| Profit Margin % | -1150.68% | -39254.06% | -19784.87% | -9330.95% |
| Operating Margin % | -1100.37% | -40174.8% | -20112.48% | -3528.46% |
| Gross Margin % | 22.06% | -1010.41% | -1071.28% | -10.93% |
| EBITDA Margin % | -1071.41% | -37170.27% | -18878.52% | -9131.19% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.